Literature DB >> 9062359

Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.

H Fujita1, S Sugiura, S Momomura, M Omata, H Sugi, K Sutoh.   

Abstract

Recent studies have revealed that familial hypertrophic cardiomyopathy (FHC) is caused by missence mutations in myosin heavy chain or other sarcomeric proteins. To investigate the functional impact of FHC mutations in myosin heavy chain, mutants of Dictyostelium discoideum myosin II equivalent to human FHC mutations were generated by site-directed mutagenesis, and their motor function was characterized at the molecular level. These mutants, i.e., R397Q, F506C, G575R, A699R, K703Q, and K703W are respectively equivalent to R403Q, F513C, G584R, G716R, R719Q, and R719W FHC mutants. We measured the force generated by these myosin mutants as well as the sliding velocity and the actin-activated ATPase activity. These measurements showed that the A699R, K703Q, and K703W myosins exhibited unexpectedly weak affinity with actin and the lowest level of force, though their ATPase activity remained rather high. F506C mutant which has been reported to have benign prognosis exhibited the least impairment of the motile and enzymatic activities. The motor functions of R397Q and G575R myosins were classified as intermediate. These results suggest that the force level of mutant myosin molecule may be one of the key factors for pathogenesis which affect the prognosis of human FHC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062359      PMCID: PMC507909          DOI: 10.1172/JCI119228

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  C-terminus on actin: spectroscopic and immunochemical examination of its role in actomyosin interactions.

Authors:  A M Duong; E Reisler
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

2.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

Authors:  E B Lankford; N D Epstein; L Fananapazir; H L Sweeney
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Role of charged amino acid pairs in subdomain-1 of actin in interactions with myosin.

Authors:  C J Miller; E Reisler
Journal:  Biochemistry       Date:  1995-02-28       Impact factor: 3.162

5.  X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-.

Authors:  A J Fisher; C A Smith; J B Thoden; R Smith; K Sutoh; H M Holden; I Rayment
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

6.  A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

Authors:  H Watkins; C MacRae; L Thierfelder; Y H Chou; M Frenneaux; W McKenna; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

7.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

Authors:  I Rayment; H M Holden; J R Sellers; L Fananapazir; N D Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Actin's view of actomyosin interface.

Authors:  C J Miller; P Cheung; P White; E Reisler
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

9.  Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.

Authors:  H Watkins; D Conner; L Thierfelder; J A Jarcho; C MacRae; W J McKenna; B J Maron; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

10.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

Authors:  H Watkins; W J McKenna; L Thierfelder; H J Suk; R Anan; A O'Donoghue; P Spirito; A Matsumori; C S Moravec; J G Seidman
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

View more
  28 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Mutation of the myosin converter domain alters cross-bridge elasticity.

Authors:  Jan Köhler; Gerhard Winkler; Imke Schulte; Tim Scholz; William McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 3.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

Review 4.  Dictyostelium myosin II as a model to study the actin-myosin interactions during force generation.

Authors:  Naoya Sasaki; Reiko Ohkura; Kazuo Sutoh
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 5.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

Review 6.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

7.  CsmA, a class V chitin synthase with a myosin motor-like domain, is localized through direct interaction with the actin cytoskeleton in Aspergillus nidulans.

Authors:  Norio Takeshita; Akinori Ohta; Hiroyuki Horiuchi
Journal:  Mol Biol Cell       Date:  2005-02-09       Impact factor: 4.138

8.  Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance.

Authors:  B Seebohm; F Matinmehr; J Köhler; A Francino; F Navarro-Lopéz; A Perrot; C Ozcelik; W J McKenna; B Brenner; T Kraft
Journal:  Biophys J       Date:  2009-08-05       Impact factor: 4.033

9.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Authors:  O Roopnarine; L A Leinwand
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

10.  Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function.

Authors:  H L Sweeney; H S Feng; Z Yang; H Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.